Navigation Links
Sectra and Philips Complete Modality Transaction
Date:9/1/2011

SHELTON, Connecticut, September 1, 2011 /PRNewswire/ --

Sectra (NASDAQ OMX Stockholm: SECT B) has completed a mammography-modality deal with Royal Philips Electronics (AEX: PHI, NYSE: PHG). Philips will pay EUR 57.5 million in a cash-on-cash and debt-free basis and take over the acquired modality operation today, September 1, 2011.

"The deal with Philips will give us the resources we need to continue our efforts and expand our business. In Medical Systems, we can concentrate on our core business and aim for a larger share of the market growth for medical imaging IT systems, which is growing rapidly," says Torbjörn Kronander, President of Sectra's medical systems operation.

     (Logo: http://www.newscom.com/cgi-bin/prnh/20110627/465018 )

The divested operation represented 14% of the Sectra Group's net sales for fiscal year 2010/2011 and has approximately 110 employees. The transaction comprises Sectra's mammography-modality operations worldwide, except for Australia and New Zealand where Sectra will continue to sell and service the unique MicroDose mammography modality under a separate distribution agreement with Philips.

The agreement includes an additional earn-out of EUR 12.5 million, which will fall due if the agreed terms and conditions are achieved over a period of five years. This transaction, excluding the possible earn-out, is estimated to generate a capital gain in terms of earnings of about SEK 300 million after tax for Sectra.

Focus ON medical IT

Sectra is one of the world's largest suppliers of medical imaging IT solutions. Sectra provides radiology, mammography, orthopeadic and rheumatology clinics with medical-imaging IT solutions and services that enhance the efficiency of medical care, contribute to raising the quality of care and optimize production. Enhancing the efficiency of healthcare for women is a priority for Sectra.

"Mammography imaging IT solutions is a niche market where Sectra holds a leading position. To further increase the value of mammography programs, customers can also add our innovative osteoporosis analysis service. We will now be working with all modality providers in the mammography market, which enhances our reputation as a highly professional and independent IT systems integrator," says Torbjörn Kronander.

For additional information:

Pictures: http://flickr.com/photos/sectramedicalsystems

Press room: http://www.sectra.com/medical/press/

About Sectra

Sectra develops and sells IT systems and products for radiology, mammography and orthopaedics. More than 1,100 hospitals, clinics and imaging centers worldwide use the systems daily, together performing over 55 million radiology examinations annually. This makes Sectra one of the world-leading companies within systems for handling digital radiology images. In Scandinavia, Sectra is the market leader with more than 50% of all film-free installations. Sectra's systems have been installed in North America, Scandinavia and most major countries in Europe and the Far East.

Sectra was founded in 1978 and has its roots in Linköping University in Sweden. The company's business operation includes cutting-edge products and services within the niche segments of medical systems and secure communication systems. Sectra has offices in 12 countries and operates through partners worldwide. Sales in the 2010/2011 fiscal year totaled SEK 784 million excluding discontinued operation. The Sectra share is quoted on the NASDAQ OMX Stockholm AB exchange. For more information, visit http://www.sectra.com.

Contact: Dr. Torbjörn Kronander, President, Sectra Imtec AB, Phone: +46-705-23-52-27

http://www.sectra.com


'/>"/>
SOURCE Sectra
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Medical Machines Online Announces Release of a Brand New Philips HeartStart AED Defibrillator
2. Cardiums InnerCool Therapies Business to Be Acquired By Royal Philips Electronics
3. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
4. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
5. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
6. Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
7. Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol
8. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
9. Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
10. Friends of the Earth Report on Biofuel Production Offers Incomplete, Outdated and Inaccurate Picture, According to Brazilian Sugarcane Industry Association
11. China Sky One Medical, Inc. Completes Acquisition of Peng Lai Jin Chuang Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... -- Financial Highlights ... unaudited)Three Months Ended December 31,Twelve Months Ended December 31,20162015% ... $           300$   ... Product Revenue 3539(10)%9498(4)%Kuvan Net Product ... 756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... , Feb. 23, 2017  Seattle,s upscale Capitol Hill neighborhood, ... strange place for a head lice treatment salon to set ... a Tuscan restaurant and a French bistro on E Madison ... "We aren,t just any old lice clinic, we pride ourselves ... comfortable, and release some of the stigma associated with lice. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Today, researchers can fast-track ... uric acid, and/or other biomarkers or SNPs of interest) using one, easy-to-collect saliva ... , the relationship between insulin and other relevant biomarkers can be extensively studied ...
(Date:2/23/2017)... ... February 22, 2017 , ... Seventy-one ... been named Fellows of the Society this year, the Fellows Committee has announced. ... fields of optics, photonics, and imaging as well as their service to the ...
Breaking Biology Technology:
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
Breaking Biology News(10 mins):